Panacea Life Sciences Holdings, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Panacea Life Sciences Holdings, Inc. (PLSH) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $8.02 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2024-04-01
- Panacea Life Sciences Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $8.02M, a 19.83% decline from fiscal 2022.
- Panacea Life Sciences Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $10.00M.
- Panacea Life Sciences Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $8.34M, a 97.26% increase from fiscal 2019.
- Panacea Life Sciences Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2019 was $4.23M, a 58.36% increase from fiscal 2018.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2023-12-31 | $8.02M 10-K · filed 2024-04-01 | |
| 2022-12-31 | $10.00M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $8.34M 10-K/A · filed 2021-04-23 | |
| 2019-12-31 | $4.23M 10-K/A · filed 2021-04-23 | |
| 2018-12-31 | $2.67M 10-K · filed 2020-05-22 | |
| 2017-12-31 | $1.28M 10-K · filed 2019-03-29 | |
| 2016-12-31 | $794.50K 10-K · filed 2018-04-02 | $795.50K 10-K · filed 2017-03-31 |
| 2015-12-31 | $250.50K 10-K · filed 2017-03-31 | |
| 2014-12-31 | $128.80K 10-K · filed 2016-02-29 |